Effects of tyrosine administration on serum biopterin in normal controls and patients with Parkinson's disease.
After administration of tyrosine, total concentration of biopterin, the cofactor for tyrosine hydroxylase, was increased in the striatum, adrenal glands, and serum of rats, and in the serum of humans. Serum biopterin is lower in patients with Parkinson's disease than in normal controls. After oral administration of tyrosine, the increase in serum biopterin concentration was smaller in patients with Parkinson's disease (less than twofold) than in healthy controls (three-to sevenfold). These results suggest that tyrosine may have a regulatory role in biopterin biosynthesis and that patients with Parkinson's disease may have some abnormality in the regulation of biopterin biosynthesis.
D000284:Administration, Oral; D000311:Adrenal Glands / Q000378:metabolism; D000409:Alanine / Q000494:pharmacology; D000818:Animals; D001708:Biopterins / Q000097:blood*; D003342:Corpus Striatum / Q000378:metabolism; D006801:Humans; D007274:Injections, Intraperitoneal; D008099:Liver / Q000378:metabolism; D008297:Male; D010300:Parkinson Disease / Q000097:blood*; D011621:Pteridines / Q000097:blood*; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors; D014443:Tyrosine / Q000008:administration & dosage / Q000494:pharmacology*
D011621:Pteridines; D001708:Biopterins; D014443:Tyrosine; D000409:Alanine